Effect of Raltegravir Intensification in the Cytokine Profile of Treated HIV+ Individuals
Background: Inflammatory markers are increased in untreated HIV infected individuals and, as immune activation, are not normalized by combination antiretroviral therapy (cART). Long term (48 weeks) intensification of cART with Raltegravir reduced CD8 T-cell activation in the Discorral and IntegRal studies. Therefore, we have evaluated the effect of Raltegravir intensification in several soluble plasma markers…